WASHINGTON, Nov 3 (Reuters) - Mylan received U.S. antitrust approval for its hostile bid for Irish-based generic drugmaker Perrigo Co under the condition Mylan sells seven drugs to Alvogen Group Inc, the Federal Trade Commission said on Tuesday.
from Reuters: New Issues News http://ift.tt/1Qa7fA8
Tidak ada komentar:
Posting Komentar